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eprivation, school and work disruptions, rib fractures, and
neumonia.
Adolescents and adults not only experience substantial
orbidity and complications from pertussis, they play an
mportant role in transmission of Bordetella pertussis to
hildren. Multiple studies have documented that parents and
ther family members are the main source of pertussis infec-
ion in infants. Of particular concern are very young infants,
ho are at greatest risk for hospitalization and mortality
rom pertussis, and who are either incompletely vaccinated
r unvaccinated.
To address these concerns, adolescent/adult-formulation
etanus-diphtheria-acellular pertussis (Tdap) vaccines,
ometimes combined with injectable polio vaccine, have
een developed. These Tdap vaccines have been shown
n clinical trials to be safe and at least as immunogenic
gainst pertussis as their analogous pediatric vaccines. In
anada and the US, Tdap vaccination is recommended for
ll adolescents and adults < 64 years of age. Emphasis is
laced on vaccinating young adolescents and on vaccinating
dults (eg, new parents, child-care workers, and certain
ealthcare-personnel) who have close contact with infants.
anadian experience suggests that Tdap vaccine usage has
ontributed to further decreases in pertussis. Full control
f this disease, however, may require decennial boosting
ith Tdap vaccine, which is currently under study.
oi:10.1016/j.ijid.2008.05.065
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pening Remarks - Adult Immunisation: Some Thoughts
. Hanna
Communicable Disease Control, Tropical Population Health
nit Network, Queensland Health, Cairns, Australia
dult immunisation can be categorised in several ways:-
mmunisation for travel - immunisation for certain occupa-
ions (eg. health-care and child-care workers)- immunisation
or those with certain medical conditions (eg. asplenia), -
mmunisation for the elderly.
Immunisation for the elderly, in particular, is gaining
reater recognition and greater credibility. Ageing pop-
lations, the increasing prevalence of certain medical
onditions in the aged, and a desire to keep the aged in opti-
al health, all have contributed to this recognition of the
eed for vaccines for, and for the delivery of these vaccines
o, the aged.
However, this greater recognition of the need has not
et been matched by greater uptake of vaccines by the
lderly, even in afﬂuent industrialised countries. For exam-
le, uptake of the annual inﬂuenza vaccine in those aged
65 years in the United States increased from 33% to 66% in
he 1990s, but has not increased since. Other countries do
ot even have mechanisms in place to determine the cov-
rage of vaccines in the elderly; in Australia, for example,
lthough inﬂuenza and pneumococcal polysaccharide vac-
ines are provided free to those aged ≥65 years, there is not
et a mechanism to determine uptake of these vaccines.
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Perhaps the main reasons for this disconnection between
ntent and outcome are that ‘‘adult immunisation is not yet
n essential element within the culture of adult medicine
or is it a health care priority in the minds of the public’’.
his suggests that increasing demand for adult immunisation
y improving professional and public awareness should be
iven greater priority; indeed this need for greater aware-
ess has been given priority in a recent policy statement on
dult immunisation from the Infectious Diseases Society of
merica.
oi:10.1016/j.ijid.2008.05.066
1.003
Vaccine for the Prevention of Herpes Zoster and Its
omplications
. Levin
University of Colorado School of Medicine, Denver, CO, USA
aricella (chickenpox) is associated with a viremia that
esults in a life-long association of the varicella-zoster virus
VZV) with neurons in sensory ganglia. VZV remains in a clin-
cally inapparent (latent) form in these neurons because of
he presence of VZV-speciﬁc immune responses that appear
t the time of the childhood varicella infection. However,
hen these responses decline, as occurs with immune sup-
ression, the latent VZV reactivates and causes herpes
oster (HZ). These same protective responses also decline
aturally as part of the aging process. This explains why
Z occurs in approximately one-quarter of all people in
heir lifetime; 20% of cases occur in those who are 50—59
ears old and 60% occur in older people (incidence is 1/100
ersons per year for those ≥60 years). Not only does the
ncidence of HZ increase with aging, but the duration and
everity of this painful disease increases with aging, as
oes its main complication - prolonged pain (post-herpetic
euralgia; PHN). Since HZ is the consequence of declining
ZV-speciﬁc immunity, it was suggested that boosting this
mmunity in older people would prevent HZ and/or lessen
ts severity. A double-blinded, placebo-controlled, trial of a
ive, attenuated, HZ vaccine has proven this hypothesis to
e correct. The HZ vaccine reduced the frequency of HZ (by
0%) and it reduced the pain and suffering (including PHN) by
65%, and as a consequence, is recommended in the United
tates for routine use in people ≥60 years of age. The details
f the clinical trial and potential issues raised by its use will
e discussed.
oi:10.1016/j.ijid.2008.05.067
1.004
erpes Zoster and Post Herpetic Neuralgia (PHN) - The
aiwan Perspective
.C. Yang
Department of Neurology, National Taiwan University, Col-
ege of Medicine, Taipei, Taiwan
he objective of this study is to estimate the incidence of
Z among the Taiwanese population, and investigate the
isease burden of HZ by analyzing the utilization of health
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care resources. Data from 2001 to 2003 were collected from
the National Health Insurance Research Database (NHIRD),
containing health insurance enrollments and claims data
from over 97% of the Taiwanese population. Incident HZ
cases were identiﬁed through HZ diagnosis codes on health
care claims. Overall incidence rates were age-and sex-
adjusted. The cost of outpatient visits and hospitalizations
were obtained. The prescription patterns of antiviral and
neuropathic pain medications were examined. The data will
be presented in the meeting.
doi:10.1016/j.ijid.2008.05.068
11.005
Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN):
Burden of Illness, Healthcare Utilization, and Costs; the
Thai Perspective
P. Pitisuttihum
Faculty of Tropical Medicine, Mahidol University, Bangkok,
Thailand
Background: Herpes Zoster is characterized by vesicular
cutaneous eruption with dermatomal distribution and is
mostly associated with debilitating pain and, later, post-
herpetic neuralgia, especially among patients aged more
than 50 years, despite early treatment with antiviral drugs.
This study aimed to measure the burden of disease, assess
the impact on quality of life, and determine healthcare
resource utilization and costs associated with HZ and PHN
in Thailand.
Methods: This was a prospective cohort study of patients
presenting with Zoster rash in 7 hospitals in Thailand. The
burden of illness and quality of life due to zoster- associated
pain were measured using the Zoster Brief Pain Inventory,
the Initial Zoster Impact Questionnaire, and the Euro-QoL.
Healthcare utilization, costs, and work-time and produc-
tivity lost due to both HZ and PHN, were measured by
simple questionnaire describing visits to physicians or clin-
ics, hospitalizations, use of other health-related services,
prescription medications, over-the-counter medications, as
well as diagnostic tests and procedures performed for the
current episode. Healthcare costs were estimated from
healthcare utilization data. Indirect costs were measured
by simple descriptive questionnaire, to determine time off
work taken by patients or caretakers, and lost income.
The above parameters were followed at each visit, at
days 0, 7, and months 1, 3, and 6.
Results: 180 patients with HZ were enrolled; 138 were
elderly (aged >50 years), 34 were HIV-infected, and 8 were
cancer patients. 160 and 104 patients completed month 3
and month 6, follow up respectively (April 10, 08). About
54% presented with rashes, primarily affected the thoracic
dermatome; 93.8% reported pain. The detailed results for
burden of illness, quality of life, and healthcare costs will
be presented.
doi:10.1016/j.ijid.2008.05.069
P
O
D
P
dited Papers) e11
ew Directions in the Treatment of Fungal Infections
invited)
2.001
he Changing Epidemiology of Fungal Infection: New
athogens and Problems
. Sathapatayavongs
Faculty of Medicine Ramathibodi Hospital, Mahidol Univer-
ity, Bangkok, Thailand
nvasive fungal infection is increasingly recognized as one of
he major causes of mortality and morbidity in healthcare.
his is due to the increase in susceptible hosts result-
ng from various factors such as intense antineoplastic and
mmunosuppressive agents, breakdown of anatomical barri-
rs, prolonged use of the intravascular catheter, parenteral
utrition, aggressive surgical procedures, broad-spectrum
ntibacterial agents, and HIV infection. Candida spp. and
spergillus spp. are the two most frequently pathogens
solated during the past 2 decades. Although both remain
ommonest pathogens, the changes in species isolated are
bserved. non-albicans Candida is increasing namely C.
labrata, C. krusei, C. tropicalis, C. parapsilosis, and apart
rom A. fumigatus, A. ﬂavus, A. niger, and A. terreus are
ncreasingly isolated. In the era of intensive chemotherapy
nd radiotherapy followed by the hematopoietic stem cell
ransplantation, Zygomycetes, Fusarium spp. Scedosporium
pp. emerge as very difﬁcult-to-treat pathogens. This may
e explained by the pattern of the use of antifungal agents:
uconazole, itraconazole, and amphotericin B. The selec-
ive pressure of these agents in the presence of prolonged
eutropenia and/or severe immunosuppression predispose
atients with these amphotericinB-resistant fungal infec-
ion. In AIDS patients, Cryptococcus neoformans is the most
ommon systemic fungal pathogen worldwide. In addition,
ndemic fungi such as Histoplasma capsulatum in USA and
enicillium marneffei in Thailand are common AIDS-related
ycoses. Another unique mycosis reported from Thailand
s pythiosis, the infection caused by Pythium insidiosum.
he most recognized form with high morbidity and mor-
ality is arteritis, commonly presented with limb gangrene,
neurysm and ultimately aortic rupture. Almost all patients
ave hemoglobinopathy-thallasemic syndrome and expose
o this organisms in the environment such as rice ﬁeld. Treat-
ent of this entity is still problematic since it is not a true
ungus and the response to the available antifungal agents
s unsatisfactory. Considering its habitat, it is likely that
ythiosis is underrecognized in the Southeast Asia region,
ne should be aware of this entity.
oi:10.1016/j.ijid.2008.05.070
2.002
harmacodynamics of Antifungal Drugs: A Strategy to
ptimize Efﬁcacy
. AndesMadison, WI, USA
harmacodynamic studies examine the relationship between
rug pharmacokinetics and outcome. These investigations
